OPINIONS
Editorials
Commentaries
Columnists


Barbara McKee: Painful program

Drugstores will turn to generic painkillers because of Medicare

By Barbara McKee / Tribune Columnist
February 1, 2005

Barbara J. McKeeThe way we dispense medication in the United States is changing as we speak.

Concerned about the new Medicare drug program, major drug chains are turning to distributing cheap, generic drugs to combat possible low Medicare reimbursement.

How do I know this? I recently spent three hours with my doctor and pharmacist, trying to figure out how I could get my regular medication, which is being discontinued. It gave me a glimpse of what millions of elderly and other chronic medication-users could go through soon.

My usual pain medication is a good generic called Endocet, used in place of Percocet. Endocet is a mixture of oxycodone and acetaminophen. A couple of months ago, my doctor heard about a cheaper generic and thought I should try it. I went along, figuring one generic is as good as the next.

Both of us couldn't have been more wrong. I had no relief from this new generic drug and was in constant pain. I thought I had to adjust to the new medication, which can take up to two weeks. But at the end of the month I had a long talk with my doctor, and he switched me back to Endocet.

To understand the difference between brand name and generic drugs, consider Crisco. Many other shortenings claim to be just as good and to use exactly the same ingredients. But the processing of the ingredients makes Crisco a better product. The same goes for brand-name drugs versus generic.

When I went to get my refill of Endocet this month, I was told that the drug chain found a cheaper version and will no longer carry Endocet. The cheaper generic does not contain acetaminophen but is being touted as the new generic for the brand-name Percocet.

I had to go back to my doctor to get him to reissue my prescription for Percocet. I complained to the pharmacist about the removal of Endocet, the good generic. She told me this was done in preparation for the new Medicare drug program, out of concern that the drug chain doesn't know exactly how much it will be reimbursed. This is bad news for those who cannot tolerate the cheap stuff.

This reminds me of a practice that began with the medication Prilosec, used for the treatment of acid-reflux disease. When the U.S. Food and Drug Administration allowed it to be sold over the counter, pharmacies began using the over-the-counter dosage to fill prescriptions for insurance payments that still covered prescription Prilosec. Boxes of Prilosec disappeared off the shelves. It was cheaper for the drugstore to use the over-the-counter Prilosec and bill insurance companies at the prescription-only rates.

Next time, my doctor will have to mark my medication "as written" on the prescription - meaning no generics. This will raise my drug costs and my insurance rates.

Misery flows downhill. Unfortunately, I'm at the bottom.

MORE MCKEE COLUMNS »

 
Search site for: Search help »